| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |